Santarus and Pharming Announce New Data From Open-Label Repeat …

Published December 2, 2013

Santarus and Pharming Announce New Data from Open-Label Repeat …
… of the pivotal Phase III clinical study with RUCONEST® (recombinant human C1 esterase inhibitor, or rhC1INH) will be featured in a poster presentation on November 9 & 10, 2013 at the 2013 American College of Allergy, Asthma & Immunology Annual …
Read more on Business Wire (press release)

John Waters Lives To Make The World A Filthier Place
I always thought there should be a sequel where Dorothy's Aunt Em puts her in a mental institution where they give her shock treatment because she can't stop talking about Oz. Dorothy tries drugs, but only poppers seem to work. So she …. 12/6 …
Read more on EDGEOnTheNet

DAYBREAK DAILY: McAuliffe to put assets into a blind trust
SPLASH: Coming soon, apparently, per the Baltimore Sun, “After months of hints and half-denials, Michael Phelps has re-entered the drug testing pool for international competition, the strongest signal yet that he's planning a return to swimming …
Read more on WJLA

New Consortia in Oncology and Metabolic Diseases Launch Efforts to Develop …
… The Center for Medical Technology Policy (CMTP) announced the leadership of two new disease-specific consortia and associated working groups of the Green Park Collaborative-USA (GPC-USA) at the Collaborative's first Annual Meeting in Baltimore last …
Read more on PR Newswire (press release)